Get started
Author

Anne Aries

Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity
2004 · Anne Aries, Pierre Paradis, et al. · Proceedings of the National Academy of Sciences · 299
Serum Response Factor-GATA Ternary Complex Required for Nuclear Signaling by a G-Protein-Coupled Receptor
2001 · Steves Morin, Pierre Paradis, et al. · Molecular and Cellular Biology · 107
Convergence of Protein Kinase C and JAK-STAT Signaling on Transcription Factor GATA-4
2005 · Jun Wang, Pierre Paradis, et al. · Molecular and Cellular Biology · 68
VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion
2018 · Rachid Lahlil, Maurice Scrofani, et al. · Stem Cell Reviews and Reports · 66
PDF
Ageing is a Risk Factor in Imatinib Mesylate Cardiotoxicity
2014 · Wael Maharsy, Anne Aries, et al. · European Journal of Heart Failure · 42
PDF
Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells
1996 · Franck Morceau, Anne Aries, et al. · Biochemical Pharmacology · 38
Anthracyclines as Tumor Cell Differentiating Agents: Effects on the Regulation of Erythroid Gene Expression
1997 · P. Jeannesson, R. Lahlil, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 35
Caspase-1 cleavage of transcription factor GATA4 and regulation of cardiac cell fate
2014 · A Aries, J Whitcomb, et al. · Cell Death and Disease · 34
PDF
Design and Validation of an Automated Process for the Expansion of Peripheral Blood-Derived CD34+ Cells for Clinical Use After Myocardial Infarction
2019 · Claire Saucourt, Sandrine Vogt, et al. · Stem Cells Translational Medicine · 21
PDF
Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells
1996 · A Aries, C Trentesaux, et al. · Blood · 19
Cyclin D2 rescues size and function of GATA4 haplo-insufficient hearts
2012 · Abir Yamak, Rana Temsah, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 18
Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells.
1994 · M N Nyoung, C Trentesaux, et al. · PubMed · 17
Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.
1993 · C Trentesaux, M N Nyoung, et al. · PubMed · 16
Development of a potency assay for CD34+ cell-based therapy
2023 · Anne Aries, Christine Vignon, et al. · Scientific Reports · 11
PDF
Industrialized GMP Production of CD34+ Cells (ProtheraCytes®) at Clinical Scale for Treatment of Ischemic Cardiac Diseases Is Feasible and Safe
2022 · Philippe Hénon, Marc Kowalczyk, et al. · Stem Cell Reviews and Reports · 11
PDF
Mechanisms of Angiotensin II‐Dependent Progression to Heart Failure
2006 · Mona Nemer, Nassim Dali‐Youcef, et al. · Novartis Foundation symposium · 10
Deciphering the Cardiovascular Potential of Human CD34+ Stem Cells
2023 · Anne Aries, Céline Zanetti, et al. · International Journal of Molecular Sciences · 9
PDF
Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia
2023 · Rachid Lahlil, Anne Aries, et al. · International Journal of Molecular Sciences · 7
PDF
Liquid Biopsy and Epigenetic Signatures in AML, ALL, and CNS Tumors: Diagnostic and Monitoring Perspectives
2025 · Anne Aries, Bernard Drénou, et al. · International Journal of Molecular Sciences · 6
PDF
Purification of Human Recombinant GATA-1 from Bacteria: Implication for Protein-Protein Interaction Studies
2001 · Zinaida Doubeikovskaia, Anne Aries, et al. · Protein Expression and Purification · 4
Differential Expression of the Tetraspanin CD9 in Normal and Leukemic Stem Cells
2021 · Rachid Lahlil, Maurice Scrofani, et al. · Biology · 1
PDF
125. Expression of GATA-1 and NFE-2 erythroid-specific transfactors during aclacinomy-cin-mediated differentiation of human erythroleukemic cells
1992 · C Trecitesaux, M Ngo Nyoung, et al. · Biomedicine & Pharmacotherapy · 1
Process Development and Manufacturing: POTENCY ASSAY DEVELOPMENT OF AN ADVANCED THERAPY MEDICINAL PRODUCT FOR POST-ACUTE MYOCARDIAL INFARCTION
2023 · I. Garitaonandia, C. Vignon, et al. · Cytotherapy
Regulation de l'expression des genes erythroides au cours de l'induction de differenciation de la lignee leucemique humaine k562 par l'aclacinomycine
1996 · Anne Aries
Molecular mechanisms of anthracyclines-mediated differentiation of human erythroleukemic cells.
1995 · Morceau, Franck, Ariès, Anne, et al. · HAL
Works count: 25
Citation count: 840
H-index: 13
I10-index: 16
Year
Topic
Type